Cancers Webinar | Plasma Oncology
the chair
8th Cancers Webinar
Plasma Oncology
Cold atmospheric plasma (CAP), also called non-thermal plasma (NTP), is a partially ionized gas that is being studied as a localized cancer therapy, in a field now coined as ‘plasma oncology’. CAP is created by applying electricity to a gas at atmospheric pressure and near room temperature and consists of neutral gas molecules, radicals, and excited species, which can rapidly react with cancerous tissue and induce therapeutic effects. These include the modulation and activation of multiple signaling pathways in cancer cells and the stimulation of host, anti-cancer immunity. Over the past decade, there is mounting evidence of the therapeutic, anti-cancer potential of CAP based on preclinical investigations: 2D and 3D in vitro studies, in silico computer modeling, and in vivo models. Now, the major challenge for the plasma oncology field is to take fundamental insights and translate this technology for clinical applications.
For this webinar, we have invited experts in the field of plasma oncology to present the state-of-the-art findings and provide insights into the next steps towards clinical translation.
Date: 24 October 2022
Time: 3:00pm CEST | 9:00am EDT | 9:00pm CST Asia
Webinar ID: 876 2112 5690
Webinar Secretariat: cancers.webinar@mdpi.com
Meet Our Speakers
Prof. Dr. Annemie Bogaerts
Research Group PLASMANT, Department of Chemistry, University of Antwerp, Wilrijk-Antwerp, Belgium;
Prof. Dr. Annemie Bogaerts is Collection Editor of Topical Collection "Plasma Oncology". Her research interests: plasma; plasma chemistry; plasma oncology; plasma medicine; plasma catalysis; computer modeling; plasma cancer immunotherapy
Dr. Angela Privat-Maldonado
Research Group PLASMANT, Department of Chemistry, and Center for Oncological Research (CORE), University of Antwerp, Wilrijk-Antwerp, Belgium;
Dr. Angela Privat-Maldonado is Collection Editor of Topical Collection "Plasma Oncology" with research interests: plasma oncology; plasma medicine; 3-dimensional in vitro cancer models; cell biology, oxidative stress, tumor microenvironment
Dr. Abraham Lin
Research Group PLASMANT, Department of Chemistry, and Center for Oncological Research (CORE), University of Antwerp, Wilrijk-Antwerp, Belgium;
Dr. Abraham Lin is Collection Editor of Topical Collection "Plasma Oncology" with research interests: plasma medicine; plasma device development; combination cancer therapy; immune modulation; tumor microenvironment; plasma dosimetry
On Monday, 24 October 2022, MDPI and the Journal Cancers organized the 8th webinar on Cancers, entitled "Plasma Oncology".
We thank the speakers for the insightful talks on the role of the immune response on plasma therapies, the importance of clinical studies, and the considerations on how to move the field of plasma oncology forward from the clinical point of view. We hope this webinar brings light to the potential of plasma therapy for cancer, and opens the discussion on how to accelerate its transition to the clinic.
The presentations were followed by a Q&A and a discussion, moderated by the Chairs. The webinar was offered via Zoom and required registration to attend. The full recording can be found here on Sciforum website. In order to stay updated on the next webinars on Cancers, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.
A topical collection in Cancers (ISSN 2072-6694). This collection belongs to the section "Cancer Therapy".
Collection Editors: Prof. Dr. Annemie Bogaerts, Dr. Angela Privat-Maldonado & Dr. Abraham Lin